Brokerages Set Simulations Plus, Inc. (NASDAQ:SLP) PT at $51.40

Simulations Plus, Inc. (NASDAQ:SLP - Get Free Report) has been assigned a consensus rating of "Buy" from the seven brokerages that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation, five have issued a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $51.40.

Several brokerages recently commented on SLP. StockNews.com downgraded shares of Simulations Plus from a "hold" rating to a "sell" rating in a research report on Monday, November 4th. BTIG Research cut their price target on shares of Simulations Plus from $60.00 to $50.00 and set a "buy" rating on the stock in a report on Thursday, October 24th. William Blair restated an "outperform" rating on shares of Simulations Plus in a report on Wednesday, November 6th. Finally, Stephens assumed coverage on Simulations Plus in a research report on Friday, November 15th. They issued an "overweight" rating and a $39.00 price objective on the stock.

Insider Transactions at Simulations Plus

In related news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $31.76, for a total transaction of $635,200.00. Following the completion of the transaction, the director now directly owns 3,442,584 shares of the company's stock, valued at approximately $109,336,467.84. This represents a 0.58 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Over the last quarter, insiders have sold 60,750 shares of company stock valued at $1,837,255. 20.90% of the stock is currently owned by corporate insiders.

Institutional Trading of Simulations Plus

A number of large investors have recently made changes to their positions in SLP. First Horizon Advisors Inc. raised its holdings in Simulations Plus by 82.6% during the 3rd quarter. First Horizon Advisors Inc. now owns 818 shares of the technology company's stock valued at $26,000 after buying an additional 370 shares during the period. nVerses Capital LLC increased its position in Simulations Plus by 1,100.0% during the third quarter. nVerses Capital LLC now owns 1,200 shares of the technology company's stock valued at $38,000 after acquiring an additional 1,100 shares during the last quarter. Quantbot Technologies LP purchased a new stake in shares of Simulations Plus in the third quarter valued at $59,000. US Bancorp DE lifted its holdings in shares of Simulations Plus by 37.0% in the 3rd quarter. US Bancorp DE now owns 4,974 shares of the technology company's stock worth $159,000 after acquiring an additional 1,343 shares during the last quarter. Finally, Los Angeles Capital Management LLC purchased a new position in shares of Simulations Plus during the 2nd quarter worth about $206,000. 78.08% of the stock is currently owned by institutional investors.

Simulations Plus Stock Down 3.1 %

Shares of NASDAQ:SLP traded down $0.99 on Friday, hitting $30.93. The company had a trading volume of 175,656 shares, compared to its average volume of 141,936. Simulations Plus has a 1 year low of $27.07 and a 1 year high of $51.22. The firm's 50-day simple moving average is $30.79 and its two-hundred day simple moving average is $36.55. The firm has a market capitalization of $620.77 million, a price-to-earnings ratio of 63.12 and a beta of 0.76.

Simulations Plus (NASDAQ:SLP - Get Free Report) last released its earnings results on Wednesday, October 23rd. The technology company reported $0.06 EPS for the quarter, beating analysts' consensus estimates of $0.04 by $0.02. The company had revenue of $18.70 million during the quarter, compared to analysts' expectations of $19.73 million. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. The firm's revenue for the quarter was up 19.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.18 EPS. Equities research analysts anticipate that Simulations Plus will post 1.1 EPS for the current year.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.